Cargando…

Thyroid function and metabolic syndrome in the population-based LifeLines cohort study

BACKGROUND: The metabolic syndrome (MetS) is a combination of unfavourable health factors which includes abdominal obesity, dyslipidaemia, elevated blood pressure and impaired fasting glucose. Earlier studies have reported a relationship between thyroid function and some MetS components or suggested...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolffenbuttel, Bruce H. R., Wouters, Hanneke J. C. M., Slagter, Sandra N., van Waateringe, Robert P., Muller Kobold, Anneke C., van Vliet-Ostaptchouk, Jana V., Links, Thera P., van der Klauw, Melanie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644133/
https://www.ncbi.nlm.nih.gov/pubmed/29037214
http://dx.doi.org/10.1186/s12902-017-0215-1
_version_ 1783271672283922432
author Wolffenbuttel, Bruce H. R.
Wouters, Hanneke J. C. M.
Slagter, Sandra N.
van Waateringe, Robert P.
Muller Kobold, Anneke C.
van Vliet-Ostaptchouk, Jana V.
Links, Thera P.
van der Klauw, Melanie M.
author_facet Wolffenbuttel, Bruce H. R.
Wouters, Hanneke J. C. M.
Slagter, Sandra N.
van Waateringe, Robert P.
Muller Kobold, Anneke C.
van Vliet-Ostaptchouk, Jana V.
Links, Thera P.
van der Klauw, Melanie M.
author_sort Wolffenbuttel, Bruce H. R.
collection PubMed
description BACKGROUND: The metabolic syndrome (MetS) is a combination of unfavourable health factors which includes abdominal obesity, dyslipidaemia, elevated blood pressure and impaired fasting glucose. Earlier studies have reported a relationship between thyroid function and some MetS components or suggested that serum free thyroxine (FT4) or free triiodothyronine (FT3) levels within the normal range were independently associated with insulin resistance. We assessed how thyroid function relates to MetS prevalence in a large population-based study. METHODS: Data of 26,719 people of western European descent, aged 18–80 years from the Dutch LifeLines Cohort study, all with normal thyroid stimulating hormone (TSH), FT4 and FT3 levels (electrochemiluminescent immunoassay, Roche Modular E170 Analyzer), were available. MetS was defined with the revised National Cholesterol Education Programs Adults Treatment Panel III (NCEP ATP III) criteria. We calculated prevalence of all MetS components according to TSH, FT4 and FT3 quartiles. RESULTS: At similar TSH levels and age (mean 45 yrs), men had significantly higher levels of FT4, FT3, blood pressure (BP), heart rate, total and LDL-cholesterol, triglycerides (TG), and creatinine, but lower HDL-cholesterol compared to women (all p < 0.001). In total, 11.8% of women and 20.7% of men had MetS. In men, lower FT4 levels were associated with higher prevalence of MetS and all MetS components. In women, lower FT4 quartile was only associated with a higher prevalence of elevated TG, waist circumference, and MetS. However, when corrected for confounding factors like age, BMI, current smoking and alcohol consumption, a significant relationship was found between FT3 and three MetS components in men, and all five components in women. Moreover, the highest quartiles of FT3 and the FT3FT4 ratio predicted a 49% and 67% higher prevalence of MetS in men, and a 62 and 80% higher prevalence in women. CONCLUSIONS: When corrected for possible confounding factors, higher plasma levels of FT3 are associated with several components of the MetS. Only in men, lower FT4 is related to MetS. In the highest FT3 and FT3FT4 quartiles, there is a 50–80% increased risk of having MetS compared to the lowest quartile. Further studies are needed to assess the possible causality of this relationship. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12902-017-0215-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5644133
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56441332017-10-26 Thyroid function and metabolic syndrome in the population-based LifeLines cohort study Wolffenbuttel, Bruce H. R. Wouters, Hanneke J. C. M. Slagter, Sandra N. van Waateringe, Robert P. Muller Kobold, Anneke C. van Vliet-Ostaptchouk, Jana V. Links, Thera P. van der Klauw, Melanie M. BMC Endocr Disord Research Article BACKGROUND: The metabolic syndrome (MetS) is a combination of unfavourable health factors which includes abdominal obesity, dyslipidaemia, elevated blood pressure and impaired fasting glucose. Earlier studies have reported a relationship between thyroid function and some MetS components or suggested that serum free thyroxine (FT4) or free triiodothyronine (FT3) levels within the normal range were independently associated with insulin resistance. We assessed how thyroid function relates to MetS prevalence in a large population-based study. METHODS: Data of 26,719 people of western European descent, aged 18–80 years from the Dutch LifeLines Cohort study, all with normal thyroid stimulating hormone (TSH), FT4 and FT3 levels (electrochemiluminescent immunoassay, Roche Modular E170 Analyzer), were available. MetS was defined with the revised National Cholesterol Education Programs Adults Treatment Panel III (NCEP ATP III) criteria. We calculated prevalence of all MetS components according to TSH, FT4 and FT3 quartiles. RESULTS: At similar TSH levels and age (mean 45 yrs), men had significantly higher levels of FT4, FT3, blood pressure (BP), heart rate, total and LDL-cholesterol, triglycerides (TG), and creatinine, but lower HDL-cholesterol compared to women (all p < 0.001). In total, 11.8% of women and 20.7% of men had MetS. In men, lower FT4 levels were associated with higher prevalence of MetS and all MetS components. In women, lower FT4 quartile was only associated with a higher prevalence of elevated TG, waist circumference, and MetS. However, when corrected for confounding factors like age, BMI, current smoking and alcohol consumption, a significant relationship was found between FT3 and three MetS components in men, and all five components in women. Moreover, the highest quartiles of FT3 and the FT3FT4 ratio predicted a 49% and 67% higher prevalence of MetS in men, and a 62 and 80% higher prevalence in women. CONCLUSIONS: When corrected for possible confounding factors, higher plasma levels of FT3 are associated with several components of the MetS. Only in men, lower FT4 is related to MetS. In the highest FT3 and FT3FT4 quartiles, there is a 50–80% increased risk of having MetS compared to the lowest quartile. Further studies are needed to assess the possible causality of this relationship. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12902-017-0215-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-16 /pmc/articles/PMC5644133/ /pubmed/29037214 http://dx.doi.org/10.1186/s12902-017-0215-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wolffenbuttel, Bruce H. R.
Wouters, Hanneke J. C. M.
Slagter, Sandra N.
van Waateringe, Robert P.
Muller Kobold, Anneke C.
van Vliet-Ostaptchouk, Jana V.
Links, Thera P.
van der Klauw, Melanie M.
Thyroid function and metabolic syndrome in the population-based LifeLines cohort study
title Thyroid function and metabolic syndrome in the population-based LifeLines cohort study
title_full Thyroid function and metabolic syndrome in the population-based LifeLines cohort study
title_fullStr Thyroid function and metabolic syndrome in the population-based LifeLines cohort study
title_full_unstemmed Thyroid function and metabolic syndrome in the population-based LifeLines cohort study
title_short Thyroid function and metabolic syndrome in the population-based LifeLines cohort study
title_sort thyroid function and metabolic syndrome in the population-based lifelines cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644133/
https://www.ncbi.nlm.nih.gov/pubmed/29037214
http://dx.doi.org/10.1186/s12902-017-0215-1
work_keys_str_mv AT wolffenbuttelbrucehr thyroidfunctionandmetabolicsyndromeinthepopulationbasedlifelinescohortstudy
AT woutershannekejcm thyroidfunctionandmetabolicsyndromeinthepopulationbasedlifelinescohortstudy
AT slagtersandran thyroidfunctionandmetabolicsyndromeinthepopulationbasedlifelinescohortstudy
AT vanwaateringerobertp thyroidfunctionandmetabolicsyndromeinthepopulationbasedlifelinescohortstudy
AT mullerkoboldannekec thyroidfunctionandmetabolicsyndromeinthepopulationbasedlifelinescohortstudy
AT vanvlietostaptchoukjanav thyroidfunctionandmetabolicsyndromeinthepopulationbasedlifelinescohortstudy
AT linkstherap thyroidfunctionandmetabolicsyndromeinthepopulationbasedlifelinescohortstudy
AT vanderklauwmelaniem thyroidfunctionandmetabolicsyndromeinthepopulationbasedlifelinescohortstudy